The present invention relates to a pharmaceutical composition in solid oral dosage form comprising (R)-7-(2-(1-(4-butoxyphenyl)-2-methylpropan-2-ylamino)-1-hydroxyethyl)-5- hydroxybenzo[d]thiazol-2(3H)-one acetate salt.
申请公布号
AU2014222362(A1)
申请公布日期
2015.07.23
申请号
AU20140222362
申请日期
2014.02.26
申请人
NOVARTIS AG
发明人
ACHOUR, MILOUD;FAIRHURST, ROBIN ALEC;GRANDEURY, ARNAUD;HATAKEYAMA, SHINJI;KOZICZAK-HOLBRO, MAGDALENA;TUFILLI, NICOLA;ULLRICH, THOMAS
